Profile
Dr. Torben S.
Nissen is a Chairman & Chief Executive Officer at Repertoire Immune Medicines, Inc., a Chairman at Etiome, Inc., an Executive Partner at Flagship Pioneering, Inc. and a Chief Executive Officer, Treasurer & Director at Torque Therapeutics, Inc. He is on the Board of Directors at Torque Therapeutics, Inc. Dr. Nissen was previously employed as an Independent Director by Axcella Health, Inc., a President by VL26, INC., a Head-Worldwide Research & Development by Pfizer Inc., a Chief Operating Officer & Executive Director by Centers for Therapeutic Innovation, a Chief Operating Officer by Ascendis Pharma A/S, a Managing Director by Maxygen, Inc., a President by Moksha8 Pharmaceuticals, Inc., and a Principal by Novo Nordisk A/S.
He also served on the board at Ring Therapeutics, Inc. He received his graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.
Torben Nissen active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/11/2016 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Chief Executive Officer | 01/01/2024 |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Founder | 01/01/2021 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Chief Executive Officer | - |
Former positions of Torben Nissen
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 01/11/2023 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Director/Board Member | 01/12/2021 |
| RUBIUS THERAPEUTICS | President | 24/07/2019 |
| PFIZER INC. | Corporate Officer/Principal | 01/11/2016 |
Centers for Therapeutic Innovation | Chief Operating Officer | 01/01/2014 |
Training of Torben Nissen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Centers for Therapeutic Innovation | |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- Torben Nissen
















